Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000280408 is a long non-coding RNA (lncRNA) identified through transcriptomic analysis in cancer research settings. It does not encode a protein and, as of current knowledge, is not considered a direct therapeutic target such as a receptor, enzyme, or transporter. Notably, its expression profile has been investigated in studies on colorectal cancer, where it may correlate with tumor progression. However, there is no direct evidence of ENSG00000280408 serving as a target for drugs either clinically or preclinically. It is described as a "novel transcript" in gene listings and lacks further published information on functional biochemistry or therapeutic applications[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ENSG00000280408 lncRNA (ENSG00000280408).